Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.00
-0.09 (-1.77%)
Oct 23, 2026, 11:18 AM EDT - Market open
Journey Medical Market Cap
Journey Medical has a market cap or net worth of $141.12 million as of October 23, 2026. It is the 22,740th most valuable company in the world and the 3,826th biggest in the United States. Its market cap has decreased by 25.81% in one year.
Market Cap
141.12M
Enterprise Value
141.02M
1-Year Change
-25.81%
Global Rank
Country Rank
#3,826 United States
Category
ChartMarket Cap Chart
Since the IPO on November 12, 2021, Journey Medical's market cap has decreased from $157.79M to $141.12M, a decrease of -10.57%. That is a compound annual growth rate of -2.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 135.48M | -35.25% |
| Dec 31, 2025 | 209.22M | 156.14% |
| Dec 31, 2024 | 81.68M | -23.38% |
| Dec 29, 2023 | 106.61M | 212.54% |
| Dec 30, 2022 | 34.11M | -61.94% |
| Dec 31, 2021 | 89.63M | -43.20% |
| Nov 12, 2021 | 157.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 241.12M |
| SIGA Technologies | 224.17M |
| Glass House Brands | 219.59M |
| ADC Therapeutics | 191.50M |
| Akebia Therapeutics | 162.19M |
| Cardiol Therapeutics | 137.87M |
| Organigram Global | 132.32M |
| Organogenesis Holdings | 127.56M |